Haematologica

Aims & Scope

Haematologica is the main tool through which the Ferrata-Storti Foundation, a non-profit organization, promotes the dissemination of new knowledge in the field of hematology. A high quality of articles, immediate free access to everything published and the lowest possible cost for authors are the principles that inspire Haematologica's management. Haematologica considers for publication manuscripts on malignant and non-malignant hematologic diseases, including hemostasis defects. The subject area of clinical manuscripts can range from etiology to diagnostics, prognosis, prevention, and treatment. Clinical studies on drugs that modify the hemostatic process for antihemorrhagic or antithrombotic purposes fall within the field of interest of Haematologica. Basic studies on hematopoiesis, blood cells, hemostasis and blood banking that have the potential for clinical relevance are also considered for publication. Haematologica does not publish the results of studies that have already been published, even partially, or are going to be published in any form, except for meeting abstracts and manuscripts released as a preprint before or during submission.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Subject Classification